STOCK TITAN

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) will participate in two investor conferences: 2024 RBC Capital Markets Global Healthcare Conference on May 14, 2024, and Bank of America Healthcare Conference 2024 on May 16, 2024. The webcasts will be available on the company's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ITCI

-5.91%
-5.91% Session move

In the trading session that priced this news, ITCI declined 5.91%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in two upcoming investor conferences:

2024 RBC Capital Markets Global Healthcare Conference
Tuesday, May 14, 2024 at 10:00 a.m. ET in New York, NY

Bank of America Healthcare Conference 2024
Thursday, May 16, 2024 at 9:20 a.m. PT (12:20 p.m. ET) in Las Vegas, NV

A live and archived webcast of the presentations can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic / Lee Roth
cradinovic@burnsmc.com / lroth@burnsmc.com
646-930-4406


FAQ

When will Intra-Cellular Therapies participate in the 2024 RBC Capital Markets Global Healthcare Conference?

Intra-Cellular Therapies will participate in the 2024 RBC Capital Markets Global Healthcare Conference on May 14, 2024.

When will Intra-Cellular Therapies participate in the Bank of America Healthcare Conference 2024?

Intra-Cellular Therapies will participate in the Bank of America Healthcare Conference 2024 on May 16, 2024.

Where can I access the webcasts of the presentations?

The webcasts can be accessed under 'Events & Presentations' in the Investor Relations section of Intra-Cellular Therapies' website at www.intracellulartherapies.com.